Health CanadaGeneral Alert
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
Published: June 29, 2021Recall ID: 62570Category: generalCountry: Canada
Reason for Recall / Hazard
COVID - Product safety
Product Description & Identification
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
Additional Source Details
| Field | Value |
|---|---|
| N I D | 62570 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/astrazeneca-covid-19-vaccine-and-covishield-risk-capillary-leak-syndrome |
| Issue | COVID - Product safety |
| Title | AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2021-06-29 |
| Organization | Marketed health products |